-
1
-
-
33646337650
-
Hepatocellular carcinoma and hepatitis B virus
-
H.L. Chan, J.J. Sung Hepatocellular carcinoma and hepatitis B virus Semin Liver Dis 26 2006 153 161
-
(2006)
Semin Liver Dis
, vol.26
, pp. 153-161
-
-
Chan, H.L.1
Sung, J.J.2
-
2
-
-
38349094747
-
High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma
-
H.L. Chan, C.H. Tse, F. Mo High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma J Clin Oncol 26 2008 177 182
-
(2008)
J Clin Oncol
, vol.26
, pp. 177-182
-
-
Chan, H.L.1
Tse, C.H.2
Mo, F.3
-
3
-
-
29944436855
-
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
-
C.J. Chen, H.I. Yang, J. Su Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level JAMA 295 2006 65 73
-
(2006)
JAMA
, vol.295
, pp. 65-73
-
-
Chen, C.J.1
Yang, H.I.2
Su, J.3
-
4
-
-
77950500095
-
Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers
-
V.W. Wong, S.L. Chan, F. Mo Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers J Clin Oncol 28 2010 1660 1665
-
(2010)
J Clin Oncol
, vol.28
, pp. 1660-1665
-
-
Wong, V.W.1
Chan, S.L.2
Mo, F.3
-
5
-
-
77952514489
-
Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection
-
H.I. Yang, M. Sherman, J. Su Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection J Clin Oncol 28 2010 2437 2444
-
(2010)
J Clin Oncol
, vol.28
, pp. 2437-2444
-
-
Yang, H.I.1
Sherman, M.2
Su, J.3
-
6
-
-
84984550778
-
Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): Development and validation of a predictive score
-
H.I. Yang, M.F. Yuen, H.L. Chan Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score Lancet Oncol 12 2011 568 574
-
(2011)
Lancet Oncol
, vol.12
, pp. 568-574
-
-
Yang, H.I.1
Yuen, M.F.2
Chan, H.L.3
-
7
-
-
56949094767
-
Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B
-
M.F. Yuen, Y. Tanaka, D.Y. Fong Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B J Hepatol 50 2009 80 88
-
(2009)
J Hepatol
, vol.50
, pp. 80-88
-
-
Yuen, M.F.1
Tanaka, Y.2
Fong, D.Y.3
-
8
-
-
53549107488
-
Meta-analysis: Treatment of hepatitis B infection reduces risk of hepatocellular carcinoma
-
J.J. Sung, K.K. Tsoi, V.W. Wong Meta-analysis: Treatment of hepatitis B infection reduces risk of hepatocellular carcinoma Aliment Pharmacol Ther 28 2008 1067 1077
-
(2008)
Aliment Pharmacol Ther
, vol.28
, pp. 1067-1077
-
-
Sung, J.J.1
Tsoi, K.K.2
Wong, V.W.3
-
9
-
-
84860529958
-
Undetectable HBV DNA at month 12 of entecavir treatment predicts maintained viral suppression and HBeAg-seroconversion in chronic hepatitis B patients at 3 years
-
G.L. Wong, V.W. Wong, H.Y. Chan Undetectable HBV DNA at month 12 of entecavir treatment predicts maintained viral suppression and HBeAg-seroconversion in chronic hepatitis B patients at 3 years Aliment Pharmacol Ther 35 2012 1326 1335
-
(2012)
Aliment Pharmacol Ther
, vol.35
, pp. 1326-1335
-
-
Wong, G.L.1
Wong, V.W.2
Chan, H.Y.3
-
10
-
-
75449107726
-
Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B
-
T.T. Chang, C.L. Lai, S. Kew Yoon Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B Hepatology 51 2010 422 430
-
(2010)
Hepatology
, vol.51
, pp. 422-430
-
-
Chang, T.T.1
Lai, C.L.2
Kew Yoon, S.3
-
11
-
-
84862664371
-
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
-
European Association For The Study Of The Liver
-
European Association For The Study Of The Liver EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection J Hepatol 57 2012 167 185
-
(2012)
J Hepatol
, vol.57
, pp. 167-185
-
-
-
12
-
-
51049107683
-
Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2008 update
-
Y.F. Liaw, N. Leung, J.H. Kao Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update Hepatol Int 2 2008 263 283
-
(2008)
Hepatol Int
, vol.2
, pp. 263-283
-
-
Liaw, Y.F.1
Leung, N.2
Kao, J.H.3
-
13
-
-
70349240414
-
Chronic hepatitis B: Update 2009
-
A.S. Lok, B.J. McMahon Chronic hepatitis B: update 2009 Hepatology 50 2009 661 662
-
(2009)
Hepatology
, vol.50
, pp. 661-662
-
-
Lok, A.S.1
McMahon, B.J.2
-
14
-
-
55349135866
-
Efficacy and safety of entecavir in patients with chronic hepatitis B and advanced hepatic fibrosis or cirrhosis
-
E. Schiff, H. Simsek, W.M. Lee Efficacy and safety of entecavir in patients with chronic hepatitis B and advanced hepatic fibrosis or cirrhosis Am J Gastroenterol 103 2008 2776 2783
-
(2008)
Am J Gastroenterol
, vol.103
, pp. 2776-2783
-
-
Schiff, E.1
Simsek, H.2
Lee, W.M.3
-
15
-
-
75349107764
-
Efficacy of entecavir in treatment-naive patients with hepatitis B virus-related decompensated cirrhosis
-
J.H. Shim, H.C. Lee, K.M. Kim Efficacy of entecavir in treatment-naive patients with hepatitis B virus-related decompensated cirrhosis J Hepatol 52 2010 176 182
-
(2010)
J Hepatol
, vol.52
, pp. 176-182
-
-
Shim, J.H.1
Lee, H.C.2
Kim, K.M.3
-
16
-
-
84875870984
-
Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis
-
[Epub ahead of print]
-
R. Zoutendijk, J.G. Reijnders, F. Zoulim Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis Gut 2012 Apr 5 [Epub ahead of print]
-
(2012)
Gut
-
-
Zoutendijk, R.1
Reijnders, J.G.2
Zoulim, F.3
-
17
-
-
80052390410
-
Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma
-
Y.J. Jin, J.H. Shim, H.C. Lee Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma J Gastroenterol Hepatol 26 2011 1380 1388
-
(2011)
J Gastroenterol Hepatol
, vol.26
, pp. 1380-1388
-
-
Jin, Y.J.1
Shim, J.H.2
Lee, H.C.3
-
18
-
-
0036779279
-
Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation
-
H.L. Chan, A.K. Chui, W.Y. Lau Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation J Med Virol 68 2002 182 187
-
(2002)
J Med Virol
, vol.68
, pp. 182-187
-
-
Chan, H.L.1
Chui, A.K.2
Lau, W.Y.3
-
19
-
-
80054724912
-
Hepatitis B surface antigen quantification: Why and how to use it in 2011 - A core group report
-
H.L. Chan, A. Thompson, M. Martinot-Peignoux Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report J Hepatol 55 2011 1121 1131
-
(2011)
J Hepatol
, vol.55
, pp. 1121-1131
-
-
Chan, H.L.1
Thompson, A.2
Martinot-Peignoux, M.3
-
20
-
-
79952231921
-
Management of hepatocellular carcinoma: An update
-
American Association for the Study of Liver D
-
J. Bruix, M. Sherman American Association for the Study of Liver D Management of hepatocellular carcinoma: an update Hepatology 53 2011 1020 1022
-
(2011)
Hepatology
, vol.53
, pp. 1020-1022
-
-
Bruix, J.1
Sherman, M.2
-
21
-
-
0033936550
-
Time-dependent ROC curves for censored survival data and a diagnostic marker
-
P.J. Heagerty, T. Lumley, M.S. Pepe Time-dependent ROC curves for censored survival data and a diagnostic marker Biometrics 56 2000 337 344
-
(2000)
Biometrics
, vol.56
, pp. 337-344
-
-
Heagerty, P.J.1
Lumley, T.2
Pepe, M.S.3
-
22
-
-
84871650559
-
Who will have the best response to entecavir?
-
G.L. Wong Who will have the best response to entecavir? J Gastroenterol Hepatol 28 2013 5 7
-
(2013)
J Gastroenterol Hepatol
, vol.28
, pp. 5-7
-
-
Wong, G.L.1
-
23
-
-
84860173190
-
Identifying hepatitis B carriers at low risk for hepatocellular carcinoma
-
H.L. Chan Identifying hepatitis B carriers at low risk for hepatocellular carcinoma Gastroenterology 142 2012 1057 1060
-
(2012)
Gastroenterology
, vol.142
, pp. 1057-1060
-
-
Chan, H.L.1
-
24
-
-
77951227166
-
Development of a non-invasive algorithm with transient elastography (Fibroscan) and serum test formula for advanced liver fibrosis in chronic hepatitis B
-
G.L. Wong, V.W. Wong, P.C. Choi Development of a non-invasive algorithm with transient elastography (Fibroscan) and serum test formula for advanced liver fibrosis in chronic hepatitis B Aliment Pharmacol Ther 31 2010 1095 1103
-
(2010)
Aliment Pharmacol Ther
, vol.31
, pp. 1095-1103
-
-
Wong, G.L.1
Wong, V.W.2
Choi, P.C.3
-
25
-
-
84983726112
-
High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load
-
e3; quiz e13-14
-
T.C. Tseng, C.J. Liu, H.C. Yang High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load Gastroenterology 142 2012 1140 1149 e3; quiz e13-14
-
(2012)
Gastroenterology
, vol.142
, pp. 1140-1149
-
-
Tseng, T.C.1
Liu, C.J.2
Yang, H.C.3
-
26
-
-
37449030467
-
Surveillance programme for hepatocellular carcinoma improves the survival of patients with chronic viral hepatitis
-
G.L. Wong, V.W. Wong, G.M. Tan Surveillance programme for hepatocellular carcinoma improves the survival of patients with chronic viral hepatitis Liver Int 28 2008 79 87
-
(2008)
Liver Int
, vol.28
, pp. 79-87
-
-
Wong, G.L.1
Wong, V.W.2
Tan, G.M.3
-
27
-
-
84859308589
-
Prevention of hepatocellular carcinoma: A concise review of contemporary issues
-
V.W. Wong, H.L. Chan Prevention of hepatocellular carcinoma: a concise review of contemporary issues Ann Hepatol 11 2012 284 293
-
(2012)
Ann Hepatol
, vol.11
, pp. 284-293
-
-
Wong, V.W.1
Chan, H.L.2
-
28
-
-
84865490229
-
Efficacy of entecavir with or without tenofovir disoproxil fumarate for nucleos(t)ide-naive patients with chronic hepatitis B
-
e1
-
A.S. Lok, H. Trinh, G. Carosi Efficacy of entecavir with or without tenofovir disoproxil fumarate for nucleos(t)ide-naive patients with chronic hepatitis B Gastroenterology 143 2012 619 628 e1
-
(2012)
Gastroenterology
, vol.143
, pp. 619-628
-
-
Lok, A.S.1
Trinh, H.2
Carosi, G.3
|